Y. Denizot et al., PAF AND HEMATOPOIESIS .4. MODIFICATIONS OF SPLEEN AND THYMUS PAF CONTENTS AFTER A SINGLE-DOSE OF THE CHEMOTHERAPEUTIC DRUG 5-FLUOROURACIL IN MICE, Cancer letters, 88(2), 1995, pp. 185-189
The spleen and thymus of mice were examined for the presence of PAF af
ter injection of 5-fluorouracil (5-FU) (200 mg/kg). A significant incr
ease of the spleen (P = 0.005) and thymus (P < 0.05) PAF concentration
s was noted 48 h after 5-FU infusion. PAF levels in thymus are similar
to those of controls from days 4 to 14. By contrast, spleen PAF signi
ficantly decreased (0.005 < P < 0.03) from days 7 to 14. Conversely, t
he 5-FU administration did not modify the spleen and plasma acetylhydr
olase activity, suggesting that the variations of PAF levels in thymus
and spleen were mainly due to differences of local PAF production. Th
us, the chemotherapeutic drug 5-FU modulates in vivo PAF production in
haematopoietic organs of mice. Considering the effects of PAF in the
processes of B- and T-cell proliferation and functions, these results
could be of importance for the role of PAF during human cancer therapy
and haematopoiesis in vivo.